Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
Subscribe To Our Newsletter & Stay Updated
